Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 11535668 Inducible monovalent antigen binding protein
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
Current Assignee
Harpoon Therapeutics
Date Filed
February 28, 2018
Date of Patent
December 27, 2022
Patent Applicant
Harpoon Therapeutics
Patent Application Number
16489523
Patent Citations
US Patent 10428120 Serum half-life extension using IgBD
US Patent 10066016 Single chain variable fragment CD3 binding proteins
US Patent 10100106 Single domain serum albumin binding protein
US Patent 11180563 FLT3 binding proteins and methods of use
Patent Jurisdiction
United States Patent and Trademark Office
Patent Number
11535668
Patent Primary Examiner
Phillip Gambel
Find more entities like US Patent 11535668 Inducible monovalent antigen binding protein
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE